IFN-g response to vaccination against tuberculosis in dairy heifers under commercial settings.
The purpose was to determine IFN-g release as a response to vaccination against tuberculosis in dairy heifers under commercial settings. Four-hundred pregnant heifers from ten herds were randomly allocated into four groups: (1) unvaccinated, (2) BCG vaccinated, (3) BCG vaccinated plus a CFPP400 μg+polygen boost, and (4) BCG vaccinated plus a CFP200 μg+polygen boost, under a completely randomized blocks design. A dose of 106CFU of BCG was delivered SC in the neck, then blood samples were taken at days 0, 30, 120, 210, 300 and 720 to estimate IFN-g release in response to bovine-PPD antigen. No significant difference (P > 0.05) was observed in IFN-g release between groups at days 0 and 120. At days 30 and 210, vaccinated groups show higher IFN-g release than the control group but only difference of group 3 was significant (P < 0.05). At day 300, group 1 showed significantly higher IFN-g release. No significant difference was observed at day 720. Using IFN-g release as a surrogate for vaccine efficacy, BCG plus a boost with CFP or CFPP combined with an adjuvant that improves cellular immune response has the potential to protect cattle against tuberculosis for moderate periods of time in vaccinated cattle under commercial settings.
Milián-Suazo
F
F
CENID-Fisiología y Mejoramiento Animal-INIFAP, Km 1 Carretera a Colón, Ajuchitlán, Qro. 76280, Mexico. milian.feliciano@inifap.gob.mx
Gutiérrez-Pabello
J A
JA
Bojorquez-Narváez
L
L
Anaya-Escalera
A M
AM
Cantó-Alarcón
G J
GJ
González-Enríquez
J L
JL
Campos-Guillén
J
J
D000822:Animal Husbandry; D000818:Animals; D001500:BCG Vaccine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002417:Cattle / Q000097:blood / Q000276:immunology / Q000382:microbiology; D005260:Female; D007371:Interferon-gamma / Q000097:blood*; D011247:Pregnancy; D014380:Tuberculosis, Bovine / Q000276:immunology / Q000517:prevention & control*
D001500:BCG Vaccine; D007371:Interferon-gamma